ARMATA PHARMACEUTICALS, INC. (ARMP) Debt Components
- 2026-06-30: Debt Instrument, Increase, Accrued InterestUSD 6 month · $8.40M; Notes Payable, CurrentUSD (m); Debt Instrument, Convertible, Beneficial Conversion FeatureUSD (m); Debt Instrument, Convertible, Stock Price TriggerUSD/shares (m).
- 2017-09-30: Debt Instrument, Increase, Accrued InterestUSD (m); Notes Payable, CurrentUSD $305.00K; Debt Instrument, Convertible, Beneficial Conversion FeatureUSD (m); Debt Instrument, Convertible, Stock Price TriggerUSD/shares (m).
- 2017-06-30: Debt Instrument, Increase, Accrued InterestUSD (m); Notes Payable, CurrentUSD $606.00K; Debt Instrument, Convertible, Beneficial Conversion FeatureUSD (m); Debt Instrument, Convertible, Stock Price TriggerUSD/shares (m).
- 2017-03-31: Debt Instrument, Increase, Accrued InterestUSD (m); Notes Payable, CurrentUSD $598.00K; Debt Instrument, Convertible, Beneficial Conversion FeatureUSD (m); Debt Instrument, Convertible, Stock Price TriggerUSD/shares (m).
ARMATA PHARMACEUTICALS, INC. Debt Components
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Debt Instrument, Increase, Accrued Interest USD | Notes Payable, Current USD | Debt Instrument, Convertible, Beneficial Conversion Feature USD | Debt Instrument, Convertible, Stock Price Trigger USD/shares |
|---|---|---|---|---|
| 2026-06-30 | 6 month · $8.40M | (m) | (m) | (m) |
| 2017-09-30 | (m) | $305.00K | (m) | (m) |
| 2017-06-30 | (m) | $606.00K | (m) | (m) |
| 2017-03-31 | (m) | $598.00K | (m) | (m) |
| 2016-12-31 | (m) | $803.00K | (m) | (m) |
| 2015-09-30 | (m) | (m) | (m) | 9 month · 7.00 |
| 2015-03-31 | (m) | (m) | 3 month · $7.11M | (m) |
| 2014-12-31 | (m) | (m) | 12 month · $27.76M | (m) |
| 2014-09-30 | (m) | (m) | 9 month · $19.40M | (m) |
| 2014-06-30 | (m) | (m) | 6 month · $6.70M | (m) |
| 2014-03-31 | (m) | (m) | 3 month · $11.88M | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |